Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2024-04-10 5:12 pm Purchase | 13G | CONTINEUM THERAPEUTICS INC CL CTNM | JOHNSON & JOHNSON JNJ | 1,979,173 10.7% | 1,979,173 (New Position) | View |
| 2024-02-13 5:07 pm Sale | 13G | JOHNSON AND JOHNSON JNJ | VANGUARD GROUP INC | 229,372,559 9.53% | -17,454,062 (-7.07%) | View |
| 2024-02-02 5:07 pm Sale | 13G | BIOMX INC PHGE | JOHNSON & JOHNSON JNJ | 2,113,402 4.6% | -20,000 (-0.94%) | View |
| 2024-02-02 4:52 pm Sale | 13G | CVRX INC CVRX | JOHNSON & JOHNSON JNJ | 4,109,336 19.2% | -237 (-0.01%) | View |
| 2024-02-02 4:32 pm Purchase | 13G | NANOBIOTIX S A SPONSORED ADS NBTX | JOHNSON & JOHNSON JNJ | 5,623,816 11.9% | 5,623,816 (New Position) | View |
| 2024-01-30 12:46 pm Sale | 13G | JOHNSON AND JOHNSON JNJ | STATE STREET CORP STT | 132,996,283 5.52% | -9,451,661 (-6.64%) | View |
| 2024-01-26 11:49 am Sale | 13G | JOHNSON AND JOHNSON JNJ | BlackRock Inc. BLK | 186,308,341 7.7% | -12,494,428 (-6.28%) | View |
| 2024-01-24 12:51 pm Purchase | 13G | KENVUE INC KVUE | JOHNSON & JOHNSON JNJ | 182,329,550 9.5% | 182,329,550 (New Position) | View |
| 2023-02-10 07:53 am Sale | 13G | JOHNSON AND JOHNSON JNJ | STATE STREET CORP STT | 142,447,944 5.45% | -2,548,183 (-1.76%) | View |
| 2023-02-09 11:25 am Purchase | 13G | JOHNSON AND JOHNSON JNJ | VANGUARD GROUP INC | 246,826,621 9.44% | 12,043,989 (+5.13%) | View |
| 2023-01-31 1:58 pm Sale | 13G | JOHNSON AND JOHNSON JNJ | BlackRock Inc. BLK | 198,802,769 7.6% | -1,218,583 (-0.61%) | View |
| 2023-01-27 11:12 am Sale | 13G | FUSION PHARMACEUTICALS INC FUSN | JOHNSON & JOHNSON JNJ | 3,670,516 8.2% | -89,118 (-2.37%) | View |
| 2023-01-11 1:00 pm Unchanged | 13G | PROTAGONIST THERAPEUTICS INC C PTGX | JOHNSON & JOHNSON JNJ | 2,449,183 4.98% | 0 (Unchanged) | View |
| 2022-11-14 2:40 pm Purchase | 13G | MEIRAGTX HLDGS PLC MGTX | JOHNSON & JOHNSON JNJ | 6,641,064 13.7% | 3,742,514 (+129.12%) | View |
| 2022-02-14 12:37 pm Purchase | 13G | JOHNSON AND JOHNSON JNJ | STATE STREET CORP STT | 144,996,127 5.51% | 966,493 (+0.67%) | View |
| 2022-02-10 08:22 am Purchase | 13G | JOHNSON AND JOHNSON JNJ | VANGUARD GROUP INC | 234,782,632 8.92% | 6,836,528 (+3.00%) | View |
| 2022-02-07 1:32 pm Purchase | 13G | CVRX INC CVRX | JOHNSON & JOHNSON JNJ | 4,109,573 19.6% | 4,109,573 (New Position) | View |
| 2022-02-01 2:42 pm Unchanged | 13G | PHASEBIO PHARMACEUTICALS INC C PHAS | JOHNSON & JOHNSON JNJ | 1,607,044 3.3% | 0 (Unchanged) | View |
| 2022-01-31 5:49 pm Purchase | 13G | JOHNSON AND JOHNSON JNJ | BlackRock Inc. BLK | 200,021,352 7.6% | 11,510,810 (+6.11%) | View |
| 2021-02-12 4:27 pm Sale | 13G | JOHNSON AND JOHNSON JNJ | STATE STREET CORP STT | 144,029,634 5.47% | -7,837,599 (-5.16%) | View |